Sputnik
The United Nations welcomed the reports that proved the high effectiveness of the Russian vaccine “Sputnik V” by more than 91%, and published by the scientific journal “The Lancet”.
The Russian Direct Investment Fund announced yesterday, Tuesday, that the prestigious scientific journal The Lancet has published the results of the third phase of clinical trials of the Russian “Sputnik V” vaccine against the Coronavirus.
The Russian Ministry of Health registered “Sputnik V” in August 2020, and it was developed in the Russian “Gamalia” Center for Epidemiology and Microbiology Research, with the support of the Direct Investment Fund, on the basis of a well-studied platform for the vectors of human adenoviruses.
According to the experimental results, the effectiveness of “Sputnik V” exceeds 98% in terms of the humoral immune response, while it is close to 100%, in terms of cellular immunity.
Source: “Novosti”
Source link